Sejong Medical Co., Ltd. Stock

Equities

A258830

KR7258830009

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 07:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
412 KRW +26.77% Intraday chart for Sejong Medical Co., Ltd. -.--% -64.17%
Sales 2022 16.08B 11.69M Sales 2023 17.99B 13.08M Capitalization 63.64B 46.27M
Net income 2022 -91.98B -66.87M Net income 2023 -23.09B -16.78M EV / Sales 2022 12.7 x
Net Debt 2022 47.82B 34.76M Net Debt 2023 72.71B 52.86M EV / Sales 2023 7.58 x
P/E ratio 2022
-1.35 x
P/E ratio 2023
-2.75 x
Employees 135
Yield 2022 *
-
Yield 2023
-
Free-Float 87.68%
More Fundamentals * Assessed data
Dynamic Chart
Sejong Medical Co., Ltd.(KOSDAQ:A258830) dropped from S&P Global BMI Index CI
Sejong Medical Co., Ltd. announced that it has received KRW 3.5 billion in funding CI
Sejong Medical Co., Ltd. announced that it has received KRW 30 billion in funding from Helixmith Co., Ltd CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 3 billion in funding CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 30 billion in funding from Helixmith Co., Ltd CI
Doowon Science Pharmaceutical Co., Ltd. announced that it expects to receive KRW 1.16 billion in funding from Sejong Medical Co., Ltd. CI
Sejong Medical Co., Ltd. agreed to acquire unknown minority stake in Doowon Science Pharmaceutical Co., Ltd. for KRW 3.5 billion. CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 3.5 billion in funding CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 19.99999948 billion in funding from CANARIABIO M Inc. CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 19.99999948 billion in funding from CANARIABIO M Inc. CI
An unknown buyer agreed to acquire 2.5679% stake in Sejong Medical Co., Ltd. from CANARIABIO M Inc. for KRW 6.3 billion. CI
Sejong Medical Co., Ltd. announced that it has received KRW 80 billion in funding from CANARIABIO M Inc. CI
CANARIABIO Inc. announced that it has received KRW 29.999997555 billion in funding from Sejong Medical Co., Ltd. CI
CANARIABIO Inc. announced that it expects to receive KRW 19.99999837 billion in funding from Sejong Medical Co., Ltd. CI
CANARIABIO M Inc. completed the acquisition of Sejong Medical Co., Ltd. (KOSDAQ : A258830) from Lee, Jae Chul & others. CI
More news
1 day+26.77%
1 month+0.49%
3 months-47.25%
6 months-69.66%
Current year-64.17%
More quotes
1 month
322.00
Extreme 322
422.00
Current year
322.00
Extreme 322
1 190.00
1 year
322.00
Extreme 322
3 920.00
3 years
322.00
Extreme 322
9 650.00
5 years
322.00
Extreme 322
9 650.00
10 years
322.00
Extreme 322
9 650.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 21-12-28
Chief Tech/Sci/R&D Officer 49 -
Director/Board Member 55 -
Members of the board TitleAgeSince
Director/Board Member 55 -
Chief Executive Officer 43 21-12-28
Director/Board Member 68 -
More insiders
SEJONG MEDICAL Co.Ltd., is a Korea-based company principally engaged in the manufacturing and sale of laparoscopic surgery equipments. The Company manufactures and sells laparoscopic surgery trocar, laparoscopic bags, and laparoscopic loop. The Company distributes its products within the domestic market and to overseas markets, including Europe, Asia and North America.
More about the company
  1. Stock Market
  2. Equities
  3. A258830 Stock